🇺🇸 FDA

Intelligence Platform

Patents

Browse 2,828 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 6756399

Use of lipoxygenase inhibitors and PPAR ligands as anti-cancer therapeutic and interventio

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jun 29 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 24 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6750239

Pyrazole-derived kinase inhibitors and uses thereof

Vertex Pharmaceuticals Incorporated · Granted Tue Jun 15 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 10 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6750241

Protein kinase inhibitors

Theravance, Inc. · Granted Tue Jun 15 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 10 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6743791

Heterocyclic inhibitors of ERK2 and uses thereof

Vertex Pharmaceuticals Incorporated · Granted Tue Jun 01 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 27 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6727251

Pyrazole compounds useful as protein kinase inhibitors

Vertex Pharmaceuticals Incorporated · Granted Tue Apr 27 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 22 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6720335

Sulfonamide inhibitors of aspartyl protease

Vertex Pharmaceuticals Incorporated · Granted Tue Apr 13 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 08 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6713444

Buforin I as a specific inhibitor and therapeutic agent for botulinum toxin B and tetanus

The United States of America as represented by the Secretary of the Army · Granted Tue Mar 30 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 25 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6706719

Hydroxamic and carboxylic acid derivatives having MMP and TNF inhibitory activity

Darwin Discovery Limited · Granted Tue Mar 16 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 11 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6706711

Pyrazole derived kinase inhibitor

Vertex Pharmaceuticals Incorporated · Granted Tue Mar 16 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 11 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6699994

Biaryl compounds as serine protease inhibitors

BioCryst Pharmaceuticals, Inc. · Granted Tue Mar 02 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 26 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6699865

Pyrazole compositions useful as inhibitors of ERK

Vertex Pharmaceuticals Incorporated · Granted Tue Mar 02 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 26 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6696452

Pyrazole compounds useful as protein kinase inhibitors

Vertex Pharmaceuticals Incorporated · Granted Tue Feb 24 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 19 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6696407

Huntington's disease treatment comprising administering aldose reductase inhibitors to inc

The Regents of the University of California · Granted Tue Feb 24 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 19 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6693130

Inhibitors of epoxide hydrolases for the treatment of hypertension

The Regents of the University of California · Granted Tue Feb 17 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 12 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6693108

Inhibitors of c-JUN N terminal kinases (JNK) and other protein kinases

Vertex Pharmaceuticals Incorporated · Granted Tue Feb 17 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 12 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6689778

Inhibitors of Src and Lck protein kinases

Vertex Pharmaceuticals Incorporated · Granted Tue Feb 10 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 05 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6689864

Cyclin dependent kinase 4 inhibitor

The Regents of the University of California · Granted Tue Feb 10 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 05 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6689784

Carbamate caspase inhibitors and uses thereof

Vertex Pharmaceuticals Incorporated · Granted Tue Feb 10 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 05 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6689782

Fungal efflux pump inhibitors

Essential Therapeutics, Inc. · Granted Tue Feb 10 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 05 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6686338

Enzyme inhibitors for metabolic redirection

BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Tue Feb 03 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 29 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6686334

Use of inhibitors of protein kinase C epsilon to treat pain

The Regents of the University of California · Granted Tue Feb 03 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 29 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6680171

I-FLICE, a novel inhibitor of tumor necrosis factor receptor-1 and CD-95 induced apoptosis

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Jan 20 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 15 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6673778

Enzyme inhibitors for metabolic redirection

BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Tue Jan 06 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 01 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6673332

Assays for inhibitors of neuronal transport of Alzheimer's amyloid precursor protein

The Regents of the University of California · Granted Tue Jan 06 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 01 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired